112 filings
DEFA14A
PLRX
Pliant Therapeutics Inc
22 Apr 24
Additional proxy soliciting materials
5:00pm
DEF 14A
PLRX
Pliant Therapeutics Inc
Definitive proxy
22 Apr 24
4:58pm
8-K
PLRX
Pliant Therapeutics Inc
12 Mar 24
Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan
7:45am
S-8
PLRX
Pliant Therapeutics Inc
27 Feb 24
Registration of securities for employees
4:20pm
10-K
2023 FY
PLRX
Pliant Therapeutics Inc
Annual report
27 Feb 24
4:14pm
8-K
k7dixx0rs
27 Feb 24
Positive interim 12-week safety and efficacy data reported from Phase 2a INTEGRIS-PSC trial in patients with PSC
4:06pm
8-K
yks3t4k5
5 Feb 24
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data
7:31am
8-K
z6p96g7rvy0affmji
9 Nov 23
Positive interim 12-week safety and efficacy data reported from Phase 2a INTEGRIS-PSC trial in patients with PSC
4:11pm
8-K
199lp4pu
3 Oct 23
Entry into a Material Definitive Agreement
4:53pm
8-K
rimeh9big5xzl8f7d
26 Sep 23
Other Events
7:34am
8-K
hcyg1jv 0og
9 Aug 23
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:05pm
8-K
qq6njy 9t
8 Jun 23
Submission of Matters to a Vote of Security Holders
4:46pm
8-K
m9ka b9oc
9 May 23
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:10pm
8-K
e0dk3o
1 May 23
Other Events
6:08am
DEFA14A
gbexi57bdaxc
27 Apr 23
Additional proxy soliciting materials
4:20pm
S-3ASR
839wmlnpq3phe6mdmq
27 Mar 23
Automatic shelf registration
4:02pm